Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 11, 2015, Pages 1461-1467

  Demir, S ^a   Olgac, M ^a   Unal, D ^a   Gelincik, A ^a   Colakoglu, B ^a   Buyukozturk, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

classification; hypersensitivty reactions to NSAID

Indexed keywords

4 AMINOPHENOL; ACETIC ACID DERIVATIVE; ACETYLSALICYLIC ACID; DICLOFENAC; DIPYRONE; ETODOLAC; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARACETAMOL; PLACEBO; PROPIONIC ACID DERIVATIVE; PROPYPHENAZONE; PYRAZOLONE DERIVATIVE; TENOXICAM;

ADULT; ALLERGIC URTICARIA; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL CLASSIFICATION; CONTROLLED STUDY; CROSS REACTION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; SINGLE BLIND PROCEDURE; SKIN DISEASE; YOUNG ADULT; ADOLESCENT; ANAPHYLAXIS; IMMUNOLOGY; MIDDLE AGED; ODDS RATIO; RISK FACTOR; SKIN TEST;

ADOLESCENT; ADULT; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS REACTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SKIN TESTS; YOUNG ADULT;

EID: 84945467073     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12689     Document Type: Article

References (29)

1. Doña I, Blanca-Lopez N, Torres MJ, Garcia-Campos J, Garcia- Nuñez I, Gõmez F, et al., Drug hypersensitivity reactions: patterns of responses, drug involved and temporal variation in a large series of patients evaluated. J Investig Allergol Clin Immunol 2012; 22: 363-371.
2. Jare EJ, Sanchez-Borges M, Cardona-Villa R, Ensina LF, Arias-Cru A, Gõmez M, et al., Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol 2014; 113: 282-289.
3. Chalabianloo F, Berstad A, Schjott J, Riedel B, Irgens A, Florvaag E,. Clinical characteristics of patients with drug hypersensitivity in Norway: a single centre study. Pharmacoepidemiol Drug Saf 2011; 20: 506-513.
4. Sanz ML, Gamboa PM, Mayorga C,. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 2009; 9: 298-304.
5. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P,. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.
6. Stevenson DD, Sanchez-Borges M, Scczeklik A,. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87: 177-180.
7. Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al., Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
8. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al., Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013; 68: 1219-1232.
9. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F,. A novel phenotype of nonsteroidal anti-inflammatory drug hypersensitivity the high risk patient. WAO J 2009; 2: 17-19.
10. Caimmi S, Caimmi D, Bousquet PJ, Demoly P,. How can we better classify NSAID hypersensitivity reactions?-Validation from a large database. Int Arch Allergy Immunol 2012; 159: 306-312.
11. Quiralte J, Castellano-Avila R, Cimbollek S,. A phenotype-based classification of NSAIDs hypersensitivity: new patients, new challenges. Allergy 2014; 69: 814-816.
12. Ayuso P, Blanca-Lopez N, Dona I, Torres MJ, Guéant-Rodríguez RM, Canto G, et al., Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy 2013; 43: 1097-1109.
13. Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al., World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol 2011; 127: 587-593.
14. Ortega N, Dona I, Moreno E, Audicana MT, Barasona MJ, Berges-Gimeno MP, et al., Practical guidelines for diagnosis hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. J Investig Allergol Clin Immunol 2014; 24: 308-323.
15. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al., Skin test concentrations for systemically administered drugs-an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013; 68: 702-712.
16. Doña I, Blanca-Lõpez N, Cornejo-García JA, Torres MJ, Laguna JJ, Fernández J, et al., Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41: 86-95.
17. Quiralte J, Blanco C, Delgado J, Ortega N, Alcntára M, Castillo R, et al., Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory drug induced reactions. J Investig Allergol Clin Immunol 2007; 17: 182-188.
18. Quiralte J,. Aspirin-induced isolated periorbital angioedema. Ann Allergy Asthma Immunol 1998; 81: 459.
19. Kim YJ, Lim KH, Kim MY, Jo EJ, Lee SY, Lee SE, et al., Cross-reactivity to acetaminophen and celecoxib according to the type of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Immunol Res 2014; 6: 156-162.
20. Shin YS, Lee YW, Choi YH, Park B, Jee YK, Choi SK, et al., Spontaneous reporting of adverse drug events by korean regional pharmacovigilance centers. Pharmacoepidemiol Drug Saf 2009; 18: 910-915.
21. Van der Klauw MM, Wilson JH, Stricker BH,. Drug associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996; 26: 1355-1363.
22. Asero R,. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin Exp Allergy 2005; 35: 713-716.
23. Caimmi S, Manca E, Caimmi D, Marseglia GL, Demoly P,. NSAID hypersensitivity in twins. Pediatr Allergy Immunol 2015; 25: 817-837.
24. Asero R,. Multiple drug allergy syndrome: a distinct clinical entity. Curr Allergy Rep 2001; 1: 18-22.
25. Pichler WJ, Daubner B, Kawabata T,. Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. J Dermatol 2011; 38: 216-221.
26. Neukomm CB, Yawalkar N, Helbling A, Pichler WJ,. T cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 2001; 11: 275-285.
27. Chiriac AM, Demoly P,. Multiple drug hypersensitivity syndrome. Curr Opin Allergy Clin Immunol 2013; 13: 323-329.
28. Sanchez-Borges M, Capriles-Hulett A,. Atopy is a risk factor for nonsteroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84: 11-16.
29. Sanchez-Borges M, Acevedo N, Caraballo L, Capriles-Hulett A, Caballero-Fonseca F,. Increased total and mite-specific IgE in patients with aspirin-induced urticaria and angioedema. J Investig Allergol Clin Immunol 2010; 20: 139-145.